Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE

Dominique Prétot, Ivette Engel-Bicik, David Kenkel, Philipp A. Kaufmann, Valerie Treyer, Alexander R. Siebenhüner